In this study, using a novel drug discovery platform that integrates computational docking, biochemical assays, and cellular reporter systems, we identified that TCZ bound with ARMC12 to disrupt its interaction with MYC in NB cells, while underlying alteration in spatial conformation of ARMC12 protein warrants further investigation. This evidence concerns the gene MYC and neuroblastoma.